查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1621593

人造血管市場：按原料、產品、應用和最終用戶分類 - 全球預測 2025-2030

Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年血管移植市值為35.1億美元，預計2024年將達到37.7億美元，複合年成長率為7.39%，到2030年將達到57.9億美元。

血管移植物是醫療設備，用於替換、繞過或修復因疾病或創傷而受損的部分血管。該市場包括合成血管移植物、生物血管移植物和生物合成血管移植物，其應用廣泛，如冠狀動脈繞道手術、血液透析機通路和周邊動脈疾病。血管移植物的需求主要是由於心血管疾病盛行率不斷上升、需要透析的終末期腎臟病率不斷上升以及易患血管疾病的老年人口不斷增加。最終使用區域包括經常進行此類手術的醫院、診所和門診手術中心。影響血管移植市場的主要成長要素包括移植材料的技術進步、對微創手術的日益偏好以及有利的報銷方案。然而，移植手術相關的高成本、移植物破損和感染等潛在併發症以及嚴格的法規環境等限制因素對市場成長構成了挑戰。該領域的發展機會包括開發具有增強生物相容性和抗血栓特性的下一代移植物，以及擴展到醫療基礎設施投資不斷增加的新興市場。創新研究領域包括生物分解性血管移植物的研究、改進組織工程技術以及利用 3D 列印技術客製化血管移植物以適應每位患者的解剖結構。他們也可能探索與生技公司在研發方面的合作，以保持技術趨勢的領先地位。血管移植市場是一個競爭激烈的市場，領先的公司投資於產品開發和策略聯盟，以擴大其全球影響力。希望利用這些機會的公司將能夠有效地利用法律規範，開發具有成本效益的製造程序，簡化核准和市場推出時間表，並開發滿足不同手術需求的產品系列。

主要市場統計
基準年[2023] 35.1億美元
預計年份 [2024] 37.7億美元
預測年份 [2030] 57.9億美元
複合年成長率（%） 7.39%

市場動態：快速發展的人工血管市場的關鍵市場洞察

供需的動態交互作用正在改變血管移植市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 世界各地與文明病盛行率不斷上升
    • 微創手術日益偏好青睞
    • 人造血管臨床試驗數量增加
  • 市場限制因素
    • 人工血管手術治療費用高
  • 市場機會
    • 改善血管移植物的設計和性能
    • 組織工程人造血管的研製
  • 市場挑戰
    • 與血管移植物相關的感染疾病

波特五力：引領人工血管市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對血管移植市場的影響

外部宏觀環境因素在塑造血管移植市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人造血管市場的競爭狀況

對血管移植市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣血管移植市場供應商績效評估

FPNV定位矩陣是評估血管移植市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了血管移植市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對血管移植市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地與文明病發生率正在增加
      • 人們對微創手術的興趣日益濃厚
      • 血管移植臨床試驗增加
    • 抑制因素
      • 人工血管手術治療費用高
    • 機會
      • 改善血管移植物的設計和性能
      • 利用組織工程開發血管移植
    • 任務
      • 血管移植相關感染疾病
  • 市場區隔分析
    • 原料：聚四氟乙烯血管移植物的使用由於其生物相容性和靈活性而迅速增加。
    • 產品：增加使用周邊血管移植物來恢復周邊動脈阻塞患者的血流
    • 應用：血管移植物在治療心血管疾病的重要用途
    • 最終使用者：血管移植物在門診手術中心（ASC）的重要應用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 人工血管市場：依原料分類

  • 生物材料
    • 人類隱靜脈和臍靜脈
    • 組織工程材料
  • 聚酯纖維
  • 聚四氟乙烯
  • 聚氨酯

第7章人工血管市場：依產品

  • 冠狀動脈繞道手術手術
  • 血管內血管支架
  • 血液透析機通路移植物
  • 周邊設備人工血管

第8章人造血管市場：依應用分類

  • 動脈瘤
  • 心血管
  • 糖尿病
  • 腎衰竭
  • 血管閉塞

第9章人工血管市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第10章北美和南美人工血管市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太人工血管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的人工血管市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Aquedeon Medical, Inc. 的 Duett 人工血管系統獲得 FDA IDE核准
    • Xeltis 的 aXess 血管移植開發獲得歐洲創新理事會的資助
    • Vygon 與 Carmat 合作開發用於人工心臟的人造血管
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Affluent Medical
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOVIC Sdn. Bhd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical, Inc.
  • Corcym Srl
  • CryoLife, Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe BV
  • Japan Lifeline Co., Ltd.
  • Lemaitre Vascular, Inc.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Perouse Medical SAS by Vygon SAS
  • Rua Life Sciences PLC
  • Shanghai Suokang Medical Implants Co. Ltd.
  • Terumo Corporation
  • Vascular Graft Solutions Ltd.
  • VUP Medical
  • WL Gore & Associates, Inc.
  • Xeltis BV
Product Code: MRR-034B50030374

The Vascular Graft Market was valued at USD 3.51 billion in 2023, expected to reach USD 3.77 billion in 2024, and is projected to grow at a CAGR of 7.39%, to USD 5.79 billion by 2030.

Vascular grafts are medical devices used to replace, bypass, or repair sections of blood vessels that are damaged due to disease or traumatic injury. The scope of this market includes synthetic, biological, and biosynthetic vascular grafts, with applications spanning coronary artery bypass, hemodialysis access, and peripheral artery diseases. The necessity for vascular grafts is primarily driven by the rising prevalence of cardiovascular diseases, increasing incidence of end-stage renal diseases necessitating dialysis, and growing geriatric population who are more prone to vascular disorders. End-use segments include hospitals, clinics, and ambulatory surgical centers where such procedures are frequently performed. Key growth factors influencing the vascular graft market include technological advancements in graft materials, increasing preference for minimally invasive surgeries, and favorable reimbursement scenarios. However, limitations such as high costs associated with graft procedures, potential complications like graft failure or infection, and stringent regulatory environments pose challenges to market growth. Opportunities in this field include developing next-generation grafts with enhanced biocompatibility and anti-thrombogenic properties, and expanding into emerging markets with growing healthcare infrastructure investments. Innovative areas for research include exploring biodegradable vascular grafts, improving tissue engineering techniques, and leveraging 3D printing technology to tailor-make vascular grafts suited for individual patient anatomy. There is also potential in exploring collaborations with biotech firms for research and development to stay ahead of technology trends. The nature of the vascular graft market is competitive, with major players investing in product development and strategic partnerships to enhance their global presence. Businesses looking to capitalize on these opportunities should focus on cost-effective manufacturing processes, streamlining approval and launch timelines, and expanding product portfolios to meet diverse surgical needs, while navigating regulatory frameworks efficiently.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 5.79 billion
CAGR (%) 7.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vascular Graft Market

The Vascular Graft Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of lifestyle-related disorders globally
    • Growing preference for minimally invasive procedures
    • Rising number of clinical trials of vascular grafts
  • Market Restraints
    • High treatment cost of vascular graft procedures
  • Market Opportunities
    • Improvements in the design and performance of vascular grafts
    • Development of tissue-engineered vascular grafts
  • Market Challenges
    • Infections associated with vascular grafts

Porter's Five Forces: A Strategic Tool for Navigating the Vascular Graft Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vascular Graft Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vascular Graft Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vascular Graft Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vascular Graft Market

A detailed market share analysis in the Vascular Graft Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vascular Graft Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vascular Graft Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vascular Graft Market

A strategic analysis of the Vascular Graft Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V..

Market Segmentation & Coverage

This research report categorizes the Vascular Graft Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Raw Material, market is studied across Biological Materials, Polyester, Polytetrafluoroethylene, and Polyurethane. The Biological Materials is further studied across Human Saphenous & Umbilical Veins and Tissue Engineered Materials.
  • Based on Product, market is studied across Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft, and Peripheral Vascular Graft.
  • Based on Application, market is studied across Aneurysm, Cardiovascular, Diabetes, Kidney Failure, and Vascular Occlusion.
  • Based on End-User, market is studied across Ambulatory Surgical Center and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of lifestyle-related disorders globally
      • 5.1.1.2. Growing preference for minimally invasive procedures
      • 5.1.1.3. Rising number of clinical trials of vascular grafts
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment cost of vascular graft procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in the design and performance of vascular grafts
      • 5.1.3.2. Development of tissue-engineered vascular grafts
    • 5.1.4. Challenges
      • 5.1.4.1. Infections associated with vascular grafts
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility
    • 5.2.2. Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries
    • 5.2.3. Application: Significant use of vascular grafts in treating cardiovascular diseases
    • 5.2.4. End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Graft Market, by Raw Material

  • 6.1. Introduction
  • 6.2. Biological Materials
    • 6.2.1. Human Saphenous & Umbilical Veins
    • 6.2.2. Tissue Engineered Materials
  • 6.3. Polyester
  • 6.4. Polytetrafluoroethylene
  • 6.5. Polyurethane

7. Vascular Graft Market, by Product

  • 7.1. Introduction
  • 7.2. Coronary Artery By-Pass Graft
  • 7.3. Endovascular Stent Graft
  • 7.4. Hemodialysis Access Graft
  • 7.5. Peripheral Vascular Graft

8. Vascular Graft Market, by Application

  • 8.1. Introduction
  • 8.2. Aneurysm
  • 8.3. Cardiovascular
  • 8.4. Diabetes
  • 8.5. Kidney Failure
  • 8.6. Vascular Occlusion

9. Vascular Graft Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital

10. Americas Vascular Graft Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vascular Graft Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Graft Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
    • 13.3.2. Xeltis' aXess Vascular Graft Development Receives Funding From European Innovation Council
    • 13.3.3. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Affluent Medical
  • 3. B. Braun Melsungen AG
  • 4. Becton, Dickinson and Company
  • 5. BIOVIC Sdn. Bhd.
  • 6. Boston Scientific Corporation
  • 7. Cardinal Health Inc.
  • 8. Cook Medical, Inc.
  • 9. Corcym S.r.l.
  • 10. CryoLife, Inc.
  • 11. Endologix Inc.
  • 12. Getinge AB
  • 13. Heart Medical Europe B.V.
  • 14. Japan Lifeline Co., Ltd.
  • 15. Lemaitre Vascular, Inc.
  • 16. Medtronic PLC
  • 17. Merit Medical Systems, Inc.
  • 18. Perouse Medical SAS by Vygon SAS
  • 19. Rua Life Sciences PLC
  • 20. Shanghai Suokang Medical Implants Co. Ltd.
  • 21. Terumo Corporation
  • 22. Vascular Graft Solutions Ltd.
  • 23. VUP Medical
  • 24. W. L. Gore & Associates, Inc.
  • 25. Xeltis B.V.

LIST OF FIGURES

  • FIGURE 1. VASCULAR GRAFT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR GRAFT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR GRAFT MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 238. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023